Amr Nassar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Glucocorticoids have been the primary treatment of graft-versus-host disease (GVHD) over the past decade. Complete responses to steroid therapy are usually expected in almost one-third of aGVHD cases and partial response is anticipated in another one-third of patients. However, for those patients not responding to corticosteroid treatment, there is no(More)
  • 1